Share chart Merck & Co
Extended chart
Simple chart
About Merck & Co
Merck & Co., Inc. действует как медицинская компания по всему миру. Он работает через два сегмента: фармацевтический сегмент и сегмент ветеринарии. Фармацевтический сегмент предлагает фармацевтические продукты для здоровья человека в областях онкологии, неотложной помощи в больницах, иммунологии, неврологии, вирусологии, сердечно-сосудистой системы, диабета и женского здоровья, а также вакцины. more details| IPO date | 1978-01-13 |
|---|---|
| ISIN | US58933Y1055 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 3.6 |
| Див.доход ап | 9.78 |
| Дивиденд ао | 3.93 |
| Дивиденд ап | 0.0228 |
| Сайт | http://www.merck.com |
| Цена ао | 87.87 |
| Change price per day: | 0% (87.87) |
|---|---|
| Change price per week: | -6.54% (94.02) |
| Change price per month: | -3.73% (91.27) |
| Change price per 3 month: | -11.64% (99.45) |
| Change price per half year: | -22.3% (113.09) |
| Change price per year: | -30% (125.52) |
| Change price per 3 year: | -0.1591% (88.01) |
| Change price per 5 year: | +8.35% (81.1) |
| Change price per 10 year: | +58.94% (55.2863) |
| Change price per year to date: | -12.18% (100.06) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard Group Inc | 244776747 | 9.66 |
| Blackrock Inc. | 201836434 | 7.97 |
| State Street Corporation | 116865977 | 4.61 |
| Wellington Management Group, LLP | 85595999 | 3.38 |
| Geode Capital Management, LLC | 55428245 | 2.19 |
| FMR, LLC | 42800017 | 1.69 |
| Morgan Stanley | 40129825 | 1.58 |
| Bank of America Corporation | 37994581 | 1.5 |
| Charles Schwab Investment Management, Inc. | 36682866 | 1.45 |
| Price (T.Rowe) Associates Inc | 30087217 | 1.19 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Jennifer L. Zachary | Executive VP & General Counsel | 2.73M | 1978 (47 years) |
| Ms. Caroline Litchfield | Executive VP & CFO | 2.8M | 1969 (56 years) |
| Mr. David Michael Williams | Executive VP and Chief Information & Digital Officer | N/A | 1969 (56 years) |
| Mr. Robert M. Davis J.D. | Chairman, President & CEO | 6.08M | 1967 (58 years) |
| Mr. Peter Dannenbaum | Vice President of Investor Relations | N/A | |
| Dr. Dean Y. Li M.D., Ph.D. | Executive VP & President of Merck Research Laboratories | 3.44M | 1963 (62 years) |
| Mr. Dalton E. Smart III | Senior VP of Finance, Principal Accounting Officer & Global Controller | N/A | 1967 (58 years) |
| Mr. Richard R. DeLuca Jr. | Executive VP & President of Merck Animal Health | 1963 (62 years) | |
| Mr. Sanat Chattopadhyay | Executive VP & President of Merck Manufacturing Division | 1960 (65 years) | |
| Ms. Cristal N. Downing | Executive VP and Chief Communications & Public Affairs Officer | 1969 (56 years) |
Address: United States, Kenilworth, NJ , 2000 Galloping Hill Road - open in Google maps, open in Yandex maps
Website: http://www.merck.com
Website: http://www.merck.com
